# Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry

> **NCT06460467** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 25 (actual)

## Conditions studied

- Meningioma

## Interventions

- **DEVICE:** scintigraphy of 177Lu-DOTATATE

## Key facts

- **NCT ID:** NCT06460467
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-02-28
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06460467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06460467, "Semi-automatic Segmentation Method for Determining 177Lu-DOTATATE Tumor Dosimetry". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06460467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*